How should I manage a 65-year-old patient with bilateral leg pain, a history of methamphetamine use in remission, L5 lumbosacral radiculopathy, hepatitis C, multiple arthralgias, chronic low back pain with right-sided sciatica, negative right lower extremity venous duplex and arterial duplex showing no significant arterial insufficiency, who requests a hydrocodone/acetaminophen (Norco) 10 mg/325 mg refill and is currently taking amitriptyline?

Management of Chronic Pain in a Patient with History of Substance Use Disorder

Do not refill the Norco prescription; instead, transition this patient to a multimodal non-opioid regimen centered on duloxetine or continuing amitriptyline optimization, NSAIDs, and physical therapy, given his history of methamphetamine use disorder and the lack of evidence supporting long-term opioid therapy for lumbosacral radiculopathy and chronic low back pain.

Rationale for Opioid Discontinuation

This patient presents multiple red flags for continued opioid therapy:

• History of substance use disorder (methamphetamine): Even in remission, this significantly increases risk for opioid misuse and addiction 1
• Lumbosacral radiculopathy at L5: Guidelines explicitly state that no medications have demonstrated efficacy for lumbosacral radiculopathy, and opioids are only second-line for neuropathic pain after other agents fail 1
• Chronic low back pain: Evidence for opioid benefits in LBP is inconclusive, with high attrition rates due to side effects and only modest improvements in analgesia or function 1
• Quadrupling of prescription opioid overdose deaths between 1999-2015 underscores the mortality risk 1

The FDA label for Norco 2 provides dosing but does not support long-term use in this clinical context.

Recommended Pharmacologic Approach

First-Line: Optimize Current Amitriptyline and Add NSAIDs

1. Continue/optimize amitriptyline: He's already on this tricyclic antidepressant (TCA), which is first-line for neuropathic pain including radiculopathy 1, 3. TCAs are recommended as part of multimodal strategy for chronic pain 3. Ensure adequate dosing (typically 25-75mg for neuropathic pain, though FDA label 4 notes dose adjustments based on response).

2. Add scheduled NSAIDs: NSAIDs are first-line for low back pain 5, 6, 7. At age 65, assess renal function and GI risk factors before prescribing. Consider gastroprotection if indicated 6.

Second-Line: Consider Duloxetine

Duloxetine (SNRI) is superior to continuing TCAs alone for this patient because:

• Strong evidence for neuropathic and radicular pain 6
• More favorable safety profile than TCAs in older adults 6
• Effective for chronic low back pain 7
• Recommended by guidelines for multimodal chronic pain management 3

Practical approach: If amitriptyline is not providing adequate relief, transition to duloxetine 30-60mg daily rather than adding opioids.

Third-Line: Gabapentinoids

If pain remains refractory:

• Gabapentin or pregabalin for neuropathic component 1, 3
• Mixed evidence in older adults 6, but reasonable option for L5 radiculopathy
• Start low (gabapentin 100-300mg TID) and titrate slowly given age

Non-Pharmacologic Interventions (Mandatory)

These are first-line management, not adjunctive 5:

1. Physical therapy/exercise therapy: Strong evidence (Category A2) for low back pain relief lasting 2-18 months 3, 5
2. Avoid bed rest 5
3. Consider epidural corticosteroid injection: Only for short-term relief of radicular pain 5, though guidelines note this can be effective for LBP and lower-extremity pain 1

Monitoring Strategy for Substance Use History

Given his methamphetamine use disorder history (even in remission):

• Screen for depression/anxiety: Chronic pain is frequently associated with these conditions 1, and amitriptyline addresses both
• Assess for signs of opioid misuse if he's been on Norco: early refill requests, dose escalation, "lost" prescriptions
• Document functional goals: Pain reduction alone is insufficient; focus on activities of daily living
• Consider urine drug screening if there's any concern about diversion or polysubstance use

Critical Pitfalls to Avoid

1. Do not prescribe opioids simply because he's requesting them: The evidence does not support efficacy for his conditions, and his substance use history dramatically increases risk 1

2. Do not assume vascular studies rule out all causes: His negative venous/arterial duplex studies exclude vascular insufficiency but don't address the neuropathic/radicular pain mechanism

3. Do not use benzodiazepines or muscle relaxants long-term: Guidelines show insufficient evidence for skeletal muscle relaxants 3, and benzodiazepines carry high sedation risk and abuse potential in this population

4. Monitor for amitriptyline side effects in older adults: Anticholinergic effects, orthostatic hypotension, cardiac conduction abnormalities 4. Consider switching to duloxetine if these emerge.

Hepatitis C Consideration

His hepatitis C status requires:

• Check liver function tests before NSAIDs or adjusting amitriptyline (both hepatically metabolized 4)
• Amitriptyline should be used with caution in impaired liver function 4
• May influence NSAID selection (avoid if significant hepatic impairment)

Communication Strategy

When declining the Norco refill, explain:

• "The evidence shows opioids don't work well for nerve pain from your back, and given your past substance use history, they carry significant risks including overdose"
• "We have better options that actually target nerve pain—like optimizing your current amitriptyline or switching to duloxetine"
• "Physical therapy has the strongest evidence for lasting improvement"
• Frame this as protecting his safety while offering more effective alternatives